Clinical Lung Cancer : Impact Factor & More
eISSN: 1938-0690pISSN: 1525-7304
Share this on:
Aims and Scope of Clinical Lung Cancer
Clinical Lung Cancer is a peer-reviewed medical journal that has been published by Elsevier since 2011. It was established by the CIG Media Group in 1999.
Key Metrics
CiteScore 
7.5
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1.18
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Clinical Lung Cancer
Clinical Lung Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | CIG MEDIA GROUP, LP |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Clinical Lung Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Clinical Lung Cancer
Incidence of Radiation Pneumonitis Following EGFR-TKI Combined With Thoracic Radiotherapy in Unresectable Stage III or IV Non-Small-Cell Lung Cancer: A Systematic Review and Meta-analysis.
- 16 Jul 2026
- Clinical lung cancer
Trends in Surgical Management of Early-stage Small Cell Lung Cancer.
- 10 Jul 2026
- Clinical lung cancer
Semiconductor FDG PET/CT for Preoperative Identification of Grade 3 Invasive Nonmucinous Adenocarcinoma.
- 4 Jul 2026
- Clinical lung cancer
Next-Generation Sequencing Completion and Timeliness Using a Reflex Testing Protocol for Patients with Stage II to IV Nonsquamous Non-Small Cell Lung Cancer.
- 2 Jul 2026
- Clinical lung cancer
Neoadjuvant Chemoimmunotherapy in Resectable NSCLC With PD-L1 Expression < 1%: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
- 1 Jul 2026
- Clinical lung cancer
Complete Spontaneous Regression of Lung Adenocarcinoma With No Residual Malignancy After Surgical Resection: A Case Report.
- 1 Jul 2026
- Clinical lung cancer
Incidence of Radiation Pneumonitis Following EGFR-TKI Combined With Thoracic Radiotherapy in Unresectable Stage III or IV Non-Small-Cell Lung Cancer: A Systematic Review and Meta-analysis.
- 16 Jul 2026
- Clinical lung cancer
Trends in Surgical Management of Early-stage Small Cell Lung Cancer.
- 10 Jul 2026
- Clinical lung cancer
Semiconductor FDG PET/CT for Preoperative Identification of Grade 3 Invasive Nonmucinous Adenocarcinoma.
- 4 Jul 2026
- Clinical lung cancer
Next-Generation Sequencing Completion and Timeliness Using a Reflex Testing Protocol for Patients with Stage II to IV Nonsquamous Non-Small Cell Lung Cancer.
- 2 Jul 2026
- Clinical lung cancer
Neoadjuvant Chemoimmunotherapy in Resectable NSCLC With PD-L1 Expression < 1%: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
- 1 Jul 2026
- Clinical lung cancer
Complete Spontaneous Regression of Lung Adenocarcinoma With No Residual Malignancy After Surgical Resection: A Case Report.
- 1 Jul 2026
- Clinical lung cancer
FAQs on Clinical Lung Cancer
How long has Clinical Lung Cancer been actively publishing? 
What is the publishing frequency of Clinical Lung Cancer?
How many articles did Clinical Lung Cancer publish last year?
What is the eISSN & pISSN for Clinical Lung Cancer?
What is Citescore for Clinical Lung Cancer?
What is SNIP score for Clinical Lung Cancer?
What is the SJR for Clinical Lung Cancer?
Who is the publisher of Clinical Lung Cancer?
